CRVS - Corvus Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts4444
Avg. Estimate-0.43-0.43-1.68-1.69
Low Estimate-0.47-0.54-1.93-2
High Estimate-0.42-0.37-1.46-1.1
Year Ago EPS-0.4-0.36-1.71-1.68
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts2233
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.59-0.48-0.46-0.4
EPS Actual-0.4-0.36-0.36-0.4
Difference0.190.120.10
Surprise %32.20%25.00%21.70%0.00%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.43-0.43-1.68-1.69
7 Days Ago-0.43-0.43-1.68-1.69
30 Days Ago-0.42-0.4-1.6-1.74
60 Days Ago-0.42-0.41-1.67-1.96
90 Days Ago-0.41-0.4-1.66-1.89
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCRVSIndustrySectorS&P 500
Current Qtr.-7.50%N/AN/A0.01
Next Qtr.-19.40%N/AN/A0.02
Current Year1.80%N/AN/A0.04
Next Year-0.60%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A